Literature DB >> 33329777

Development of alveolar-pleural fistula during hepatectomy - A case report.

Jun Hyun Kim1, Sunghyeok Park1, Ji Yeon Kim1.   

Abstract

BACKGROUND: An Alveolar-pleural fistula is communication between the alveoli and the pleural space that may result in intractable pneumothorax, severe infection, respiratory failure, physical weakness, and even death. CASE: A 70-year-old male underwent right hepatectomy with a cystic mass of the liver. During the operation, peak airway pressure abruptly increased and a serous fluid was regurgitated through the endotracheal tube. Lung isolation was immediately performed with a double-lumen endotracheal tube. Approximately 1,000 ml of exudate was drained through endotracheal tube. Thoracostomy was performed at right lung. Analysis of fluid from endotracheal tube and pleural effusion consistent with parapneumonic effusion.
CONCLUSIONS: We presented a case of alveolar-pleural fistula caused by pneumonia presenting with massive exudate fluid regurgitated from the endotracheal tube that was managed with bronchial suction, lung isolation, and thoracostomy and improved without surgical repair of the fistula. Copyright: © Anesthesia and Pain Medicine.

Entities:  

Keywords:  Fistula; Hepatectomy; One lung ventilation; Pleural effusion

Year:  2019        PMID: 33329777      PMCID: PMC7713794          DOI: 10.17085/apm.2019.14.4.456

Source DB:  PubMed          Journal:  Anesth Pain Med (Seoul)        ISSN: 1975-5171


An Alveolar-pleural fistula (APF) is communication between the alveoli and the pleural space that may result in intractable pneumothorax, severe infection, respiratory failure, physical weakness, and even death [1,2]. APF is usually not visible on bronchoscopy and diagnosed clinically [2,3]. In addition, APF rarely requires surgical intervention. However, when conservative treatment fails, interventions such as hydrogel application, blood patch, unidirectional valve and surgical repair are required [4-7]. We report a case of APF presenting with massive fluid regurgitated from an endotracheal tube during general anesthesia which was managed with bronchial suction, lung isolation and thoracostomy.

CASE REPORT

A 70-year-old male (170 cm, 59 kg) was admitted for a cystic mass (10.4 × 7.9 × 7.6 cm) of the liver and decided to undergo right hepatectomy. The patient had a medical history of hypertension and diabetes mellitus. Pre-operative transthoracic echocardiography revealed a left ventricular ejection fraction of 44% and severe hypokinesia of the left ventricle. Coronary angiography showed no significant stenosis. Pulmonary function tests demonstrated a restrictive ventilation defect. Positron emission tomography-computed tomography (PET-CT) revealed pleural effusion and consolidation in the right lower lobe (Fig. 1). Laboratory findings were as follows: hemoglobin, 12.9 g/dl, white blood cell, 7,100 /μl, platelet, 339,000 /μl, C-reactive protein, 11.1 mg/dl.
Fig. 1

Pleural effusion and consolidation in pre-operative computed tomography (arrowhead: pleural effusion, arrow: consolidation).

Pleural effusion and consolidation in pre-operative computed tomography (arrowhead: pleural effusion, arrow: consolidation). The patient’s vital signs were stable prior to general anesthesia. General anesthesia was induced with 50 mg of propofol and rocuronium 50 mg and maintained with 0.2 μg/kg/ min of remifentanil and 5 vol% of desflurane. Tidal volume and respiration rate were set to 400 ml and 13 times/min, espectively. Positive end-expiratory pressure of 5 cmH2O was applied, and peak inspiratory pressure (PIP) was 20 cmH2O. At four hours after the beginning of the operation, PIP abruptly increased to 32 cmH2O and a large amount of serous fluid was regurgitated through the endotracheal tube (ETT) (Figs. 2 and 3). However, hypoxia did not occur at FiO2 0.5. PaO2 and PaCO2 were within normal range and oxygen saturation was 100% during the entire intra-operative period. The endotracheal tube was exchanged for a 35 Fr left doublelumen endotracheal tube (DLT) and tracheal suction was performed continuously. Approximately 1,000 ml of yellowish fluid was regurgitated through the right side lumen of the DLT within 30 min. Right-sided thoracostomy was performed following hepatectomy, and 300 ml of pleural effusion was drained through the chest tube. Air leakage was observed through the chest tube during positive pressure ventilation. We could not detect and localize abnormal lesion with bronchoscopy. Any gross defect of diaphragm was not observed at operation field. The oxygen saturation of the patient had been consistently maintained at 100%.
Fig. 2

Serous fluid regurgitated through the right side lumen of double lumen tube.

Fig. 3

Large amount of fluid regurgitated through the endotracheal tube.

Serous fluid regurgitated through the right side lumen of double lumen tube. Large amount of fluid regurgitated through the endotracheal tube. Total operation time was 7 h and estimated blood loss was about 9,000 ml. Nine liters of crystalloid fluid, 550 ml of colloid fluid, 5 units of packed red blood cells and 10 units of fresh frozen plasma were infused. Urine output during the operation was 790 ml. Post-operational hemoglobin level decreased to 9.1 g/dl after the operation. The patient was transferred to the intensive care unit (ICU) with intubated state. Laboratory findings of the drained fluid from chest tube and the DLT revealed that it was parapneumonic exudate (pH 7.12, glucose 37 mg/dl, protein 3.31 g/ dl, albumin 1.63 g/dl, lactate dehydrogenase 346 IU/L, cholesterol 18.2 mg/dl). The patient was diagnosed with pneumonia and treated with pleural drainage and antibiotics. The volume of fluid drained through the ETT and the chest tube gradually decreased. The patient was extubated on postoperative day 5 and discharged from the ICU (Fig. 4).
Fig. 4

(A) Preoperative chest radiography showing right costophrenic angle blunting and elevation of diaphragm due to liver mass. (B) Chest radiography on postoperative day 1 showing pleural effusion and pulmonary edema. (C) Chest radiography on postoperative day 5 showing improving of pleural effusion and consolidation of right lung.

(A) Preoperative chest radiography showing right costophrenic angle blunting and elevation of diaphragm due to liver mass. (B) Chest radiography on postoperative day 1 showing pleural effusion and pulmonary edema. (C) Chest radiography on postoperative day 5 showing improving of pleural effusion and consolidation of right lung.

DISCUSSION

An APF is a communication between the pulmonary parenchyma, distal to a segmental bronchus, and the pleural space. Common causes of APFs are invasive thoracic procedure such as lung biopsy, thoracentesis, and thoracic surgery. Other causes include necrotizing pneumonia and abscess, cancer, tuberculosis, infarction, bronchiectasis, trauma or barotrauma [2]. Without appropriate management, APF can lead to persistent air leaks, which are associated with prolonged hospital stays and high morbidity. Conservative managements of APF include ventilator strategies to reduce fistula flow, one lung ventilation, chest tube placement, or endobronchial valves. If these strategies are not successful, further interventions including chemical pleurodesis, autologous blood patch pleurodesis, or unidirectional valve device are needed [8,9]. There were several case reports of APF. The first reported case of APF detected during general anesthesia was described by Woo et al. [10] They suggested that APF developed before surgery due to thoracentesis, whereas our patient did not undergone any invasive procedure of lung. There are several case reports which is not associated with invasive thoracic procedures. El-Sameed et al. [7] reported cases of APF associated with tuberculosis. APF developed during positive pressure ventilation at ICU in a patient with pneumonia was reported by Wiaterek et al. [6]. Our case is different with these three cases because APF developed and detected with pleural effusion regurgitation during the surgery in a patient who had not undergone invasive thoracic procedure. Any fistula between the pleural space and lung parenchyma, such as BPF or APF, pulmonary edema, and reexpansion pulmonary edema can be considered as a cause of regurgitated fluid through the endotracheal tube. Pulmonary edema was excluded from the differential diagnosis in this case because the regurgitated fluid was different from pink frothy sputum and oxygenation was maintained. In the present case, pleural effusion and consolidation in the right lung were observed on preoperative PET-CT. The patient had no respiratory symptoms preoperatively, and our patient did not undergo lung surgery or any thoracic procedures. Therefore, we considered that an APF occurred during the surgery and pleural effusion was regurgitated through a fistula in the right lung. In addition, Manipulation of the liver during hepatectomy can facilitate the development of pleural effusion as a result of injury to the diaphragm, obstruction of the thoracic venous or lymphatic systems, or surgical manipulation of the hepatic coronary ligament [11-13]. The massive effusion observed during surgery in our patient could be attributed to hepatectomy. We assumed that barotrauma due to mechanical ventilation caused a fistula, with subsequent regurgitation of the pleural effusion. We immediately performed lung isolation with a DLT to protect the opposite side of the lung and reduce air leakage. In conclusion, we presented a case of APF developed during general anesthesia presenting with massive exudate fluid regurgitated from an endotracheal tube that was managed with bronchial suction, lung isolation, and thoracostomy, and improved without surgical repair of the fistula.
  13 in total

1.  Endoscopic treatment of persistent alveolar-pleural air leaks with a unidirectional endobronchial valve.

Authors:  Antoni Rosell; Rosa López-Lisbona; Noelia Cubero; Carme Obiols; Francisco Rivas; Jordi Dorca
Journal:  Arch Bronconeumol       Date:  2011-03-21       Impact factor: 4.872

Review 2.  Management of Persistent Air Leaks.

Authors:  Karen C Dugan; Balaji Laxmanan; Septimiu Murgu; D Kyle Hogarth
Journal:  Chest       Date:  2017-03-04       Impact factor: 9.410

3.  Ease of use of watanabe spigot for alveolopleural fistulas.

Authors:  Nicole Weinreb; David Riker; John Beamis; Carla Lamb
Journal:  J Bronchology Interv Pulmonol       Date:  2009-04

4.  Endobronchial valves in the management of broncho-pleural and alveolo-pleural fistulae.

Authors:  Y El-Sameed; A Waness; I Al Shamsi; A C Mehta
Journal:  Lung       Date:  2012-01-14       Impact factor: 2.584

Review 5.  Bronchopleural fistula after lung ablation: Experience in two cases and literature review.

Authors:  A Zheng; X Yang; X Ye; G Huang; Z Wei; J Wang; X Han; X Ni; M Meng
Journal:  Indian J Cancer       Date:  2015-12       Impact factor: 1.224

6.  Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases.

Authors:  Tian Yang; Jin Zhang; Jun-Hua Lu; Guang-Shun Yang; Meng-Chao Wu; Wei-Feng Yu
Journal:  World J Surg       Date:  2011-09       Impact factor: 3.352

7.  Single centre experience with surgical treatment of hilar cholangiocarcinoma.

Authors:  N Vladov; Ts Lukanova; I Takorov; V Mutafchiyski; I Vasilevski; S Sergeev; E Odisseeva
Journal:  Chirurgia (Bucur)       Date:  2013 May-Jun

8.  Treatment of alveolar-pleural fistula with endobronchial application of synthetic hydrogel.

Authors:  Hiren J Mehta; Paras Malhotra; Abbie Begnaud; Andrea M Penley; Michael A Jantz
Journal:  Chest       Date:  2015-03       Impact factor: 9.410

Review 9.  The past, current and future of diagnosis and management of pleural disease.

Authors:  Jason Akulian; David Feller-Kopman
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

10.  Can Peripheral Bronchopleural Fistula Demonstrated on Computed Tomography be Treated Conservatively? A Retrospective Analysis.

Authors:  Maho Tsubakimoto; Sadayuki Murayama; Rin Iraha; Hisashi Kamiya; Nanae Tsuchiya; Tsuneo Yamashiro
Journal:  J Comput Assist Tomogr       Date:  2016 Jan-Feb       Impact factor: 1.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.